Clinical trials
Atherosclerosis trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 12 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute for Atherosclerosis Research, Russia | 5 |
| I.M. Sechenov First Moscow State Medical University | 4 |
| Meshalkin Research Institute of Pathology of Circulation | 4 |
| GlaxoSmithKline | 3 |
| Novartis Pharmaceuticals | 3 |
| Russian Cardiology Research and Production Center | 3 |
| Ryazan State Medical University | 2 |
| Ural State Medical University | 2 |
| AtheroNova Inc. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 38 |
| Coronary Artery Disease | 11 |
| Cardiovascular Diseases | 9 |
| Peripheral Arterial Disease | 6 |
| Carotid Artery Diseases | 5 |
| Stroke | 5 |
| Coronary Disease | 4 |
| Acute Coronary Syndrome | 3 |
| Heart Diseases | 3 |
| Inflammation | 3 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.